Safaroghli-Azar Ava相关文献与解析，生知库

Safaroghli-Azar, Ava; Mekonnen, Laychiluh B; Hassankhani, Ramin; Lenjisa, Jimma; Basnet, Sunita Kc; Batayneh, Hajer; Rahaman, Muhammed H; Wang, Shudong

CDK4

肿瘤

肿瘤免疫

乳腺癌

发表日期：2025

文献求助收藏

Apoptin Overexpression Efficiently Amplified Cytotoxic Effects of PI3K Inhibition Using BKM120 in Lymphoblastic Leukemia Cell Lines.

在淋巴母细胞白血病细胞系中，凋亡蛋白过表达可有效增强PI3K抑制剂BKM120的细胞毒性作用

期刊:Advanced Pharmaceutical Bulletin

影响因子:4.1

doi:10.34172/apb.2022.064

Anjam-Najmedini Ali, Vahabpour Rohollah, Safaroghli-Azar Ava, Kazemi Alireza, Movahhed Parvaneh, Momeny Majid, Bashash Davood

The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19

淋巴细胞亚群的作用、淋巴细胞减少症的病理生理学及其在新冠肺炎预后和治疗中的意义

期刊:International Immunopharmacology

影响因子:4.7

doi:10.1016/j.intimp.2021.107586

Delshad, Mahda; Tavakolinia, Naeimeh; Pourbagheri-Sigaroodi, Atieh; Safaroghli-Azar, Ava; Bagheri, Nader; Bashash, Davood

Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity

从 COVID-19 的角度看血小板；血小板减少症的病理生理学及其作为预后和治疗契机的意义

期刊:International Immunopharmacology

影响因子:4.7

doi:10.1016/j.intimp.2021.107995

Delshad, Mahda; Safaroghli-Azar, Ava; Pourbagheri-Sigaroodi, Atieh; Poopak, Behzad; Shokouhi, Shervin; Bashash, Davood

血小板

发表日期：2021

文献求助收藏

The PI3K/Akt signaling axis in Alzheimer's disease: a valuable target to stimulate or suppress?

阿尔茨海默病中的PI3K/Akt信号通路：是刺激还是抑制的有效靶点？

期刊:Cell Stress & Chaperones

影响因子:3.2

doi:10.1007/s12192-021-01231-3

Razani, Elham; Pourbagheri-Sigaroodi, Atieh; Safaroghli-Azar, Ava; Zoghi, Anahita; Shanaki-Bavarsad, Mahsa; Bashash, Davood

Evaluation of hTERT, KRT7, and survivin in urine for noninvasive detection of bladder cancer using real-time PCR

利用实时PCR检测尿液中hTERT、KRT7和survivin的表达水平，以用于膀胱癌的无创检测

期刊:BMC Urology

影响因子:1.9

doi:10.1186/s12894-021-00838-z

Yahyazadeh, Reza; Bashash, Davood; Ghaffari, Parisa; Kord, Saeid; Safaroghli-Azar, Ava; Ghaffari, Seyed H

NF-κB-dependent Mechanism of Action of c-Myc Inhibitor 10058-F4: Highlighting a Promising Effect of c-Myc Inhibition in Leukemia Cells, Irrespective of p53 Status

c-Myc抑制剂10058-F4的NF-κB依赖性作用机制：揭示c-Myc抑制在白血病细胞中具有潜在疗效，且不受p53状态的影响

期刊:Iranian Journal of Pharmaceutical Research

影响因子:1.8

doi:10.22037/ijpr.2020.112926.14018

Sayyadi, Mohammad; Safaroghli-Azar, Ava; Safa, Majid; Abolghasemi, Hassan; Momeny, Majid; Bashash, Davood

Inhibition of Cyclin-dependent Kinase (CDK) Decreased Survival of NB4 Leukemic Cells: Proposing a p53-Independent Sensitivity of Leukemic Cells to Multi-CDKs Inhibitor AT7519

抑制细胞周期蛋白依赖性激酶 (CDK) 可降低 NB4 白血病细胞的存活率：提示白血病细胞对多重 CDK 抑制剂 AT7519 的敏感性不依赖于 p53

期刊:Iranian Journal of Pharmaceutical Research

影响因子:1.8

doi:10.22037/ijpr.2020.113170.14148

Pourbagheri-Sigaroodi, Atieh; Safaroghli-Azar, Ava; Shanaki, Mehrnoosh; Yousefi, Amir-Mohammad; Anjam Najmedini, Ali; Bashash, Davood

PI3K Abrogation Using Pan-PI3K Inhibitor BKM120 Gives Rise to a Significant Anticancer Effect on AML-Derived KG-1 Cells by Inducing Apoptosis and G2/M Arrest

使用泛PI3K抑制剂BKM120抑制PI3K活性，可通过诱导细胞凋亡和G2/M期阻滞，对AML来源的KG-1细胞产生显著的抗癌作用。

期刊:Turkish Journal of Hematology

影响因子:1.3

doi:10.4274/tjh.galenos.2020.2019.0440

Sadeghi, Soroush; Esmaeili, Shadi; Pourbagheri-Sigaroodi, Atieh; Safaroghli-Azar, Ava; Bashash, Davood

Apoptosis

发表日期：2020

文献求助收藏

CDK Blockade Using AT7519 Suppresses Acute Myeloid Leukemia Cell Survival through the Inhibition of Autophagy and Intensifies the Anti-leukemic Effect of Arsenic Trioxide

使用 AT7519 阻断 CDK 可通过抑制自噬来抑制急性髓系白血病细胞的存活，并增强三氧化二砷的抗白血病作用。

期刊:Iranian Journal of Pharmaceutical Research

影响因子:1.8

doi:10.22037/ijpr.2019.112560.13827

Zabihi, Mitra; Safaroghli-Azar, Ava; Gharehbaghian, Ahmad; Allahbakhshian Farsani, Mehdi; Bashash, Davood

A novel CDK4 inhibitor for myeloid protection in chemotherapy-treated triple-negative breast Cancer

一种新型 CDK4 抑制剂用于化疗治疗的三阴性乳腺癌的髓系保护

Apoptin Overexpression Efficiently Amplified Cytotoxic Effects of PI3K Inhibition Using BKM120 in Lymphoblastic Leukemia Cell Lines.

在淋巴母细胞白血病细胞系中，凋亡蛋白过表达可有效增强PI3K抑制剂BKM120的细胞毒性作用

The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19

淋巴细胞亚群的作用、淋巴细胞减少症的病理生理学及其在新冠肺炎预后和治疗中的意义

Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity

从 COVID-19 的角度看血小板；血小板减少症的病理生理学及其作为预后和治疗契机的意义

The PI3K/Akt signaling axis in Alzheimer's disease: a valuable target to stimulate or suppress?

阿尔茨海默病中的PI3K/Akt信号通路：是刺激还是抑制的有效靶点？

Evaluation of hTERT, KRT7, and survivin in urine for noninvasive detection of bladder cancer using real-time PCR

利用实时PCR检测尿液中hTERT、KRT7和survivin的表达水平，以用于膀胱癌的无创检测

NF-κB-dependent Mechanism of Action of c-Myc Inhibitor 10058-F4: Highlighting a Promising Effect of c-Myc Inhibition in Leukemia Cells, Irrespective of p53 Status

c-Myc抑制剂10058-F4的NF-κB依赖性作用机制：揭示c-Myc抑制在白血病细胞中具有潜在疗效，且不受p53状态的影响

Inhibition of Cyclin-dependent Kinase (CDK) Decreased Survival of NB4 Leukemic Cells: Proposing a p53-Independent Sensitivity of Leukemic Cells to Multi-CDKs Inhibitor AT7519

抑制细胞周期蛋白依赖性激酶 (CDK) 可降低 NB4 白血病细胞的存活率：提示白血病细胞对多重 CDK 抑制剂 AT7519 的敏感性不依赖于 p53

PI3K Abrogation Using Pan-PI3K Inhibitor BKM120 Gives Rise to a Significant Anticancer Effect on AML-Derived KG-1 Cells by Inducing Apoptosis and G2/M Arrest

使用泛PI3K抑制剂BKM120抑制PI3K活性，可通过诱导细胞凋亡和G2/M期阻滞，对AML来源的KG-1细胞产生显著的抗癌作用。

CDK Blockade Using AT7519 Suppresses Acute Myeloid Leukemia Cell Survival through the Inhibition of Autophagy and Intensifies the Anti-leukemic Effect of Arsenic Trioxide

使用 AT7519 阻断 CDK 可通过抑制自噬来抑制急性髓系白血病细胞的存活，并增强三氧化二砷的抗白血病作用。